"E-abstracts" for the 2015 American Society of Clinical Oncology (ASCO) annual meeting are abstracts that have been accepted for publication with all other abstracts from the meeting, but will not be summarized in either an oral or poster presentation.

The list below contains the titles and authors of all ASCO 2015 multiple myeloma e-abstracts. Each entry in the list also includes a link to the full text of the relevant abstract at the ASCO website.

The Beacon also has similar lists of ASCO 2015 multiple myeloma-related oral pre­sentations, poster pre­sentations, and education session presentations as well as news articles about multiple myeloma at the ASCO 2015 meeting.

e19529 - Characteristics and survival of African American (AA) newly diagnosed multiple myeloma (NDMM) patients (Pts): A report from the Connect MM Registry

Kathleen Toomey, Cristina Gasparetto, Jatin J. Shah, Rafat Abonour, Jayesh Mehta, Mohit Narang, Howard R. Terebelo, James W. Hardin, Shankar Srinivasan, Gail Larkins, Rosanna J. Ricafort, Yasir M. Nagarwala, Robert M. Rifkin (abstract)

e19530 - Bone marrow micro-environmental CD4+ and CD8+ lymphocyte infiltration patterns significantly define overall- and progression free survival in standard risk multiple myeloma: An analysis from the Austrian Myeloma Registry (AMR)

Ella Willenbacher, Wolfgang Willenbacher, Claudia Zeller-Riese, Rainer Biedermann, Roman Weger, Karin Joehrer, Andrea Brunner (abstract)

e19531 - Real world impact of treatment-induced peripheral neuropathy (TIPN) on patient reported outcomes (PROs) in patients with multiple myeloma (MM) in the United States

Mark S. Walker, Ze Cong, Kevin B. Knopf, Sanjay Kumar Aggarwal, Jiandong Kerr, Arthur C. Houts (abstract)

e19532 - A retrospective analysis of upfront tandem autologous stem cell transplantation (ASCT) for high-risk (HR) myeloma (MM) patients (Pts)

Sara Farshchi Zarabi, Gurdeep Parmar, Esther Masih-Khan, Sophia Farooki, Christine Chen, Vishal Kukreti, Anca Prica, Rodger Tiedemann, Suzanne Trudel, Donna Ellen Reece (abstract)

e19533 - A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo

Matthias Peipp, Martin Gramatzki, Renate Burger, Katja Klausz, Christian Kellner, Andreas Guenther (abstract)

e19534 - Inhibition of Siglec-15 to prevent bone loss in the 5T2MM model of multiple myeloma

Gilles Tremblay, Anna Moraitis, Karin Vanderkerken, Mario Filion (abstract)

e19535 - Synchronous and metachronous second malignancies in multiple myeloma (MM)

Jennifer A Wilkinson, Mark A Fiala, Ravi Vij, Joseph Finney, Keith Stockerl-Goldstein, Tanya Marya Wildes (abstract)

e19536 - Impact of novel therapies on multiple myeloma survival in the US: Current and future outcomes

Amar Drawid, Satyin Kaura, Daniel Kiely, Mohamad A. Hussein, Malik Kaman, Nisha Gilra, Brian G. Durie (abstract)

e19537 - Interim analysis of a phase II trial of nab-paclitaxel in patients with very advanced relapsed/refractory multiple myeloma (RR-MM)

Allison Claire Rosenthal, Rafael Fonseca, Joseph Mikhael, A. Keith Stewart, Angela Mayo, Marta Chesi, Heidi Kosiorek, P. Leif Bergsagel (abstract)

e19538 - Bloodless transplants for multiple myeloma are feasible and yield similar results as matched controls

Chikaodili Olusola Obidike, Ajay K. Nooka, Jonathan L. Kaufman, Leonard T. Heffner, Amelia A. Langston, Sagar Lonial (abstract)